首页> 外文期刊>Annals of clinical biochemistry. >The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue.
【24h】

The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue.

机译:碱性磷酸酶抑制剂对从人乳腺组织分离的前脂肪细胞中细胞内脂质蓄积的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: A previous study has demonstrated that alkaline phosphatase (AP) may play a role in the control of intracellular lipid accumulation in the rodent preadipocyte cell line, 3T3-L1. The present study investigated whether AP may have a similar function in preadipocytes isolated from human mammary gland tissue. METHODS: Preadipocyte maturation was induced in the presence or absence of the tissue non-specific AP inhibitors levamisole and histidine, and the tissue-specific AP inhibitor PheGlyGly. Cellular AP activity and adipogenesis were both assessed at 0 and 12 days post-induction of differentiation. RESULTS: After differentiation, AP activity increased 5.1 +/- 1.3-fold in the absence and 8.9 +/- 2.8-fold (P < 0.05) in the presence of levamisole. However, adipogenesis increased 1.95 +/- 0.11-fold in the absence but only 1.36 +/- 0.06-fold (P < 0.001) in the presence of levamisole. There was a 4.2 +/- 2.2-fold increase in AP activity in the absence and a 0.51 +/- 0.46-fold (P < 0.05) decrease in the presence of histidine. Adipogenesis increased 2.09 +/- 0.35-fold in the absence of histidine but only 1.22 +/- 0.30-fold (P < 0.05) in the presence of histidine. PheGlyGly had no effects. Fluorescent microscopy showed AP activity was localized to the triglyceride-containing droplets of the cell. CONCLUSION: This is the first study to show that tissue non-specific AP inhibitors can block adipogenesis in human preadipocytes.
机译:背景:先前的研究表明,碱性磷酸酶(AP)可能在啮齿动物前脂肪细胞细胞系3T3-​​L1的细胞内脂质蓄积的控制中发挥作用。本研究调查了AP在从人乳腺组织分离的前脂肪细胞中是否具有类似的功能。方法:在存在或不存在组织非特异性AP抑制剂左旋咪唑和组氨酸以及组织特异性AP抑制剂PheGlyGly的情况下诱导脂肪细胞成熟。在分化诱导后0和12天均评估了细胞AP活性和脂肪形成。结果:分化后,在没有左旋咪唑的情况下,AP活性增加了5.1 +/- 1.3倍,在有左旋咪唑的情况下增加了8.9 +/- 2.8倍(P <0.05)。但是,在不存在脂肪形成的情况下,脂肪生成增加了1.95 +/- 0.11倍,但是在存在左咪唑的情况下仅增加了1.36 +/- 0.06倍(P <0.001)。在不存在组氨酸的情况下,AP活性增加了4.2 +/- 2.2倍,在组氨酸存在下的活性降低了0.51 +/- 0.46倍(P <0.05)。在不存在组氨酸的情况下,脂肪生成增加了2.09 +/- 0.35倍,但是在存在组氨酸的情况下,脂肪生成仅增加了1.22 +/- 0.30倍(P <0.05)。 PheGlyGly没有作用。荧光显微镜显示,AP活性位于细胞中含甘油三酸酯的液滴中。结论:这是第一项显示组织非特异性AP抑制剂可以阻断人脂肪细胞脂肪形成的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号